MIDODRINE HCL 2.5 MG TABLET
For 30 tablets
Pharmacies pay
$2.21 filed
30 × $0.07366 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$18.62 filed
30 × $0.62053 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
8.4× estimated
Medicare paid 8.4× what pharmacies pay.
Part D averages every strength and form sold under “Midodrine HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$7.54 estimated
$2.21 + $0.33 (15%) + $5.00 fee per fill = $7.54
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
MIDODRINE HCL 2.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as midodrine hydrochloride.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 19 labelers (the companies named on the label) for its NDCs, among them Upsher-Smith laboratories, LLC, Mylan Pharmaceuticals Inc. and Major Pharmaceuticals.
FDA’s Established Pharmacologic Class for it is alpha-Adrenergic Agonist.
The NADAC file of 2026-10-14 prices it under 24 NDCs (National Drug Codes); the FDA directory lists 21 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $2.21 for 30 tablets (30 × $0.07366 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-10-07. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 19 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Major Pharmaceuticals | 2 | $0.07366 per EA filed |
| NorthStar RxLLC | 2 | $0.07366 per EA filed |
| Advagen Pharma Limited | 1 | $0.07366 per EA filed |
| Alembic Pharmaceuticals Inc. | 1 | $0.07366 per EA filed |
| American Health Packaging | 1 | $0.07366 per EA filed |
| Apotex Corp | 1 | $0.07366 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.07366 per EA filed |
| AvPAK | 1 | $0.07366 per EA filed |
| Avet Pharmaceuticals Inc. | 1 | $0.07366 per EA filed |
| Lifestar Pharma LLC | 1 | $0.07366 per EA filed |
| Mylan Pharmaceuticals Inc. | 1 | $0.07366 per EA filed |
| NorthStar Rx LLC | 1 | $0.07366 per EA filed |
| Novugen Pharma (USA) LLC | 1 | $0.07366 per EA filed |
| Par Health USA, LLC | 1 | $0.07366 per EA filed |
| Rising Pharma Holdings, Inc. | 1 | $0.07366 per EA filed |
| TruPharma, LLC | 1 | $0.07366 per EA filed |
| Upsher-Smith laboratories, LLC | 1 | $0.07366 per EA filed |
| Xiromed, LLC | 1 | $0.07366 per EA filed |
| Zydus Pharmaceuticals (USA) Inc. | 1 | $0.07366 per EA filed |
| Not listed as a package in the FDA directory | 3 | $0.07366 per EA filed |
When these prices took effect
- 2026-10-07 · 1 NDC · $0.07366 per EA filed
- 2026-09-30 · 3 NDCs · $0.07366 per EA filed
- 2026-09-23 · 20 NDCs · $0.07366 per EA filed
All 24 NDCs, with labeler and price
- 00245-0211-11 · Upsher-Smith laboratories, LLC · $0.07366 per EA · eff. 2026-09-23 filed
- 00378-1901-01 · Mylan Pharmaceuticals Inc. · $0.07366 per EA · eff. 2026-09-23 filed
- 00904-6817-06 · Major Pharmaceuticals · $0.07366 per EA · eff. 2026-09-23 filed
- 00904-6817-61 · Major Pharmaceuticals · $0.07366 per EA · eff. 2026-09-23 filed
- 23155-0969-01 · Avet Pharmaceuticals Inc. · $0.07366 per EA · eff. 2026-10-07 filed
- 49884-0814-01 · Par Health USA, LLC · $0.07366 per EA · eff. 2026-09-23 filed
- 50268-0561-11 · not listed as a package in the FDA directory · $0.07366 per EA · eff. 2026-09-23 filed
- 50268-0561-15 · AvPAK · $0.07366 per EA · eff. 2026-09-23 filed
- 52817-0323-10 · TruPharma, LLC · $0.07366 per EA · eff. 2026-09-23 filed
- 59651-0246-01 · Aurobindo Pharma Limited · $0.07366 per EA · eff. 2026-09-23 filed
- 60505-1320-01 · Apotex Corp · $0.07366 per EA · eff. 2026-09-23 filed
- 60687-0387-01 · American Health Packaging · $0.07366 per EA · eff. 2026-09-23 filed
- 60687-0387-11 · not listed as a package in the FDA directory · $0.07366 per EA · eff. 2026-09-23 filed
- 62332-0338-31 · Alembic Pharmaceuticals Inc. · $0.07366 per EA · eff. 2026-09-23 filed
- 64980-0433-01 · Rising Pharma Holdings, Inc. · $0.07366 per EA · eff. 2026-09-23 filed
- 68382-0737-01 · Zydus Pharmaceuticals (USA) Inc. · $0.07366 per EA · eff. 2026-09-23 filed
- 70700-0157-01 · Xiromed, LLC · $0.07366 per EA · eff. 2026-09-23 filed
- 70756-0010-11 · Lifestar Pharma LLC · $0.07366 per EA · eff. 2026-09-23 filed
- 72603-0605-01 · NorthStar Rx LLC · $0.07366 per EA · eff. 2026-09-23 filed
- 72603-0906-01 · not listed as a package in the FDA directory · $0.07366 per EA · eff. 2026-09-30 filed
- 72603-0906-05 · NorthStar RxLLC · $0.07366 per EA · eff. 2026-09-30 filed
- 72603-0906-10 · NorthStar RxLLC · $0.07366 per EA · eff. 2026-09-30 filed
- 72888-0112-01 · Advagen Pharma Limited · $0.07366 per EA · eff. 2026-09-23 filed
- 82293-0003-10 · Novugen Pharma (USA) LLC · $0.07366 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
2 other products in the NADAC file share the FDA nonproprietary name midodrine hydrochloride with MIDODRINE HCL 2.5 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| MIDODRINE HCL 2.5 MG TABLET this page | $0.07366 per EA filed | $0.62053 per EA filed |
| MIDODRINE HCL 5 MG TABLET | $0.11131 per EA filed | $0.62053 per EA filed |
| MIDODRINE HCL 10 MG TABLET | $0.15125 per EA filed | $0.62053 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 24 NDCs’ NADAC prices is $0.07366 per EA filed.
Of the 59 other products in FDA’s alpha-Adrenergic Agonist class priced per EA, 59 have a higher middle NADAC price and 0 a lower one. The one in the middle is GNP FEXOFENADINE-PSE ER 60-120, at $0.48321 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $18.62 for 30 tablets, at an average of $0.62053 per EA in 2024 (2024-01-01 to 2024-12-31) for “Midodrine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 1,625,675 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for MIDODRINE HCL 2.5 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Midodrine HCl / Midodrine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- BRIMONIDINE 0.2% EYE DROP
- EPINEPHRINE 0.15 MG AUTO-INJCT
- BRIMONIDINE-TIMOLOL 0.2%-0.5%
- COMBIGAN 0.2%-0.5% EYE DROPS
- SIMBRINZA 1%-0.2% EYE DROP